Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
188.89
+0.73 (0.39%)
Oct 7, 2025, 4:00 PM EDT - Market closed
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 31, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
$656,242
Profits / Employee
$164,091
Market Cap
454.91B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 138,100 | 6,200 | 4.70% |
Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
Dec 31, 2022 | 152,700 | 11,000 | 7.76% |
Dec 31, 2021 | 141,700 | 7,200 | 5.35% |
Dec 31, 2020 | 134,500 | 2,300 | 1.74% |
Dec 29, 2019 | 132,200 | -2,900 | -2.15% |
Dec 30, 2018 | 135,100 | 1,100 | 0.82% |
Dec 31, 2017 | 134,000 | 7,600 | 6.01% |
Dec 31, 2016 | 126,400 | -700 | -0.55% |
Dec 31, 2015 | 127,100 | 600 | 0.47% |
Dec 28, 2014 | 126,500 | -1,600 | -1.25% |
Dec 29, 2013 | 128,100 | 500 | 0.39% |
Dec 30, 2012 | 127,600 | 9,700 | 8.23% |
Dec 31, 2011 | 117,900 | 3,900 | 3.42% |
Dec 31, 2010 | 114,000 | -1,500 | -1.30% |
Dec 31, 2009 | 115,500 | -3,200 | -2.70% |
Dec 28, 2008 | 118,700 | -500 | -0.42% |
Dec 30, 2007 | 119,200 | -3,000 | -2.45% |
Dec 31, 2006 | 122,200 | 6,600 | 5.71% |
Dec 31, 2005 | 115,600 | 5,600 | 5.09% |
Dec 31, 2004 | 110,000 | -1,000 | -0.90% |
Dec 28, 2003 | 111,000 | 3,000 | 2.78% |
Dec 29, 2002 | 108,000 | 6,000 | 5.88% |
Dec 30, 2001 | 102,000 | 1,000 | 0.99% |
Dec 31, 2000 | 101,000 | 3,200 | 3.27% |
Dec 31, 1999 | 97,800 | 4,700 | 5.05% |
Dec 31, 1998 | 93,100 | 2,600 | 2.87% |
Dec 28, 1997 | 90,500 | 1,200 | 1.34% |
Dec 29, 1996 | 89,300 | 7,000 | 8.51% |
Dec 31, 1995 | 82,300 | 800 | 0.98% |
Dec 31, 1994 | 81,500 | -100 | -0.12% |
Dec 31, 1993 | 81,600 | -3,300 | -3.89% |
Dec 31, 1992 | 84,900 | 2,200 | 2.66% |
Dec 31, 1991 | 82,700 | 500 | 0.61% |
Dec 31, 1990 | 82,200 | -900 | -1.08% |
Dec 31, 1989 | 83,100 | 1,800 | 2.21% |
Dec 31, 1988 | 81,300 | 3,100 | 3.96% |
Dec 31, 1987 | 78,200 | 1,100 | 1.43% |
Dec 31, 1986 | 77,100 | 2,200 | 2.94% |
Dec 31, 1985 | 74,900 | 700 | 0.94% |
Dec 31, 1984 | 74,200 | -3,200 | -4.13% |
Dec 31, 1983 | 77,400 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
JNJ News
- 42 minutes ago - Johnson & Johnson ordered to pay $966 million in talc cancer case after jury finds company liable - New York Post
- 11 hours ago - LA County Jury Hits Johnson & Johnson with Nearly $1 Billion Verdict - Business Wire
- 16 hours ago - Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer case - Reuters
- 19 hours ago - TREMFYA® (guselkumab) is first and only IL-23 inhibitor to demonstrate sustained clinical and endoscopic outcomes with a fully subcutaneous regimen through 48 weeks in ulcerative colitis - PRNewsWire
- 19 hours ago - Icotrokinra data in ulcerative colitis show potential for a standout combination of therapeutic benefit and a favorable safety profile in once-daily pill - PRNewsWire
- 19 hours ago - Johnson & Johnson Unveils New Data Demonstrating Superior Clarity of Vision and Comfort of ACUVUE OASYS MAX 1-Day for ASTIGMATISM, and MULTIFOCAL for ASTIGMATISM Contact Lenses - PRNewsWire
- 1 day ago - Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Business Wire
- 1 day ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha